Current Report Filing (8-k)
08 March 2023 - 9:10AM
Edgar (US Regulatory)
00-0000000 true American Depositary Shares, each representing one- half of one ordinary share, nominal value €0.10 per share false 0001613780 0001613780 2023-03-07 2023-03-07 0001613780 us-gaap:CommonStockMember 2023-03-07 2023-03-07 0001613780 dei:AdrMember 2023-03-07 2023-03-07
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
March 7, 2023
Date of Report (Date of earliest event reported)
DBV Technologies S.A.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
| France |
|
001-36697 |
|
Not applicable |
(State or other jurisdiction of incorporation) |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
|
|
|
|
|
177-181 avenue Pierre Brossolette 92120 Montrouge France |
|
Not Applicable |
| (Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including area code: +33 1 55 42 78 78
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
|
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
| Ordinary shares, nominal value €0.10 per share |
|
n/a |
|
The Nasdaq Stock Market LLC * |
| American Depositary Shares, each representing one- half of one ordinary share, nominal value €0.10 per share |
|
DBVT |
|
The Nasdaq Stock Market LLC |
| * |
Not for trading, but only in connection with the listing of the American Depositary Shares on The Nasdaq Stock Market LLC. |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
On March 7, 2023, DBV Technologies S.A. issued a press release entitled “DBV Technologies Announces First Patient Screened in VITESSE Phase 3 Clinical Trial in Peanut Allergic Children 4 - 7 Years Old.” The full text of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.
| Item 9.01 |
Financial Statements and Exhibits |
(d) Exhibits
|
|
|
| Exhibit
No. |
|
Description |
|
|
| 99.1 |
|
Press Release, dated March 7, 2023 |
|
|
| 104 |
|
Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
| Date: March 7, 2023 |
|
DBV TECHNOLOGIES S.A. |
|
|
|
|
|
|
|
|
By: |
|
/s/ Sébastien Robitaille |
|
|
|
|
Name: |
|
Sébastien Robitaille |
|
|
|
|
Title: |
|
Chief Financial Officer |
DBV Technologies Boulogn... (GM) (USOTC:DBVTF)
Historical Stock Chart
From May 2024 to Jun 2024
DBV Technologies Boulogn... (GM) (USOTC:DBVTF)
Historical Stock Chart
From Jun 2023 to Jun 2024
